Trevena to Present at the 2019 Cantor Global Healthcare Conference
Trevena to Participate in Upcoming Conferences in September 2019
Trevena Advances NDA Resubmission Activities for Oliceridine
Trevena Reports Second Quarter 2019 Results
Trevena to Report Second Quarter 2019 Results on August 7, 2019
Trevena Appoints Barry Shin as Chief Financial Officer
Trevena Announces Publication of APOLLO-2 Results in Pain Practice
Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine
Trevena to Participate in Upcoming Conferences in June 2019
Trevena Reports First Quarter 2019 Results